Physiologically driven nanodrug delivery system for targeted lung cancer treatment
Lung cancer remains a leading cause of cancer-related deaths globally, and a significant number of patients are ineligible for surgery, while chemoradiotherapy often shows limited efficacy, a systemic distribution, a low drug concentration at tumor sites, severe side effects, and the emergence of dr...
Saved in:
Main Authors: | Shiying Zhang (Author), Xia Li (Author), Yang Liu (Author), Hui Li (Author), Zhiyue Zhang (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitochondria-Targeting Chemodynamic Therapy Nanodrugs for Cancer Treatment
by: Qiaohui Chen, et al.
Published: (2022) -
Nucleus-Targeting Phototherapy Nanodrugs for High-Effective Anti-Cancer Treatment
by: Xingyu Long, et al.
Published: (2022) -
Advances in therapeutic nanodrug delivery systems for infectious lung diseases: a review
by: Gang Sheng, et al.
Published: (2022) -
Nanodrug Delivery Systems for Myasthenia Gravis: Advances and Perspectives
by: Jiayan Huang, et al.
Published: (2024) -
Nanodrug Delivery in Reversing Multidrug Resistance in Cancer Cells
by: Sonali eKapse-Mistry, et al.
Published: (2014)